Elevated levels of matrix metalloprotein-3 in patients with coronary aneurysm: A case control study

Current Controlled Trials in Cardiovascular Medicine

Volumn 5, Issue , 2004, Pages

  Tengiz, Istemihan ^a   Ercan, Ertugrul ^a   Aliyev, Emil ^a   Sekuri, Cevad ^b   Duman, Can ^c   Altuglu, Imre ^d  

^a Central Hospital Izmir   (Turkey)

^b KENT HOSPITAL   (Turkey)

^c KOCAELI UNIVERSITY   (Turkey)

^d EGE UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; INTERSTITIAL COLLAGENASE; MATRIX METALLOPROTEINASE; SCLEROPROTEIN; STROMELYSIN;

ADULT; ARTERY INJURY; ARTERY WALL; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORONARY ARTERY ANEURYSM; CORONARY ARTERY DISEASE; DISEASE PREDISPOSITION; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; ENZYME DEGRADATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNOASSAY; MALE; PATHOGENESIS; PROTEIN DEGRADATION; STABLE ANGINA PECTORIS; TURBIDIMETRY;

EID: 27544501677     PISSN: 14686694     EISSN: 14686694     Source Type: Journal    
DOI: 10.1186/1468-6708-5-10     Document Type: Article

References (46)

1. Sharipa OM, Shemin RJ: Aneurysmal coronary artery disease. Chest 1977, 111:796-799.
2. Burns CA, Cowley MJ, Wechsler AS, Vetrovec GW: Coronary aneurysms: A case report and review. Cathet Cardiovasc Diagn 1992, 27:106-112.
3. Befeler B, Aranda MJ, Embi A, Mullin FL, El-Sherif N, Lazzara R: Coronary artery aneurysms: Study of the etiology, clinical course and effect on left ventricular function and prognosis. Am J Med 1977, 62:597-607.
4. Swaye PS, Fisher LD, Litwin P, Vignola PA, Judkins MP, Kemp HG, Mudd JG, Gosselin AJ: Aneurysmal coronary artery disease. Circulation 1983, 67:134-138.
5. Virmani R, Robinowitz M, Atkinson JB, Forman MB, Silver MD, McAllister HA: Acquired coronary arterial aneurysms: an autopsy study of 52 patients. Hum Pathol 1986, 17:575-583.
6. Demopoulos VP, Olympios CD, Fakiolas CN, Pissimissis EG, Economides NM, Adamopoulou E, Foussas SG, Cokkinos DV: The natural history of aneurysmal coronary artery disease. Heart 1997, 78:136-141.
7. Robinson FC: Aneurysms of the coronary arteries. Am Heart J 1985, 109:129-135.
8. Syed M, Lesch M: Coronary artery aneurysm: A review. Prog Cardiovasc Dis 1997, 40:77-84.
9. Dollery C, McEwan J, Henney A: Matrix metalloproteinases and cardiovascular disease. Circ Res 1995, 77:863-868.
10. Birkedal-Hansen H, Moore W, Bodden MK, Windsor LJ, Birkedal-Hansen B, DeCarlo A, Engler JA: Matrix metalloproteinases: a review. Crit Rev Oral Biol Med 1993, 4:197-250.
11. Armonk NY: Regulation of metalloproteinases and their inhibitors in atheroma. In The vulnerable atherosclerotic plaque: understanding, identification, and modification Edited by: Fuster v. Futura Publishing Company, Inc; 2001, Chapter 22
12. Matrisian LM: Metalloproteinases and their inhibitors in matrix remodeling. Trends Genet 1990, 6:121-125.
13. Chase AJ, Bond M, Crook MF, Newby AC: Role of nuclear factor-kb activation in metalloproteinase-1, -3, and -9 secretions by human macrophages in vitro and rabbit foam cells produced in vivo. Arterioscler Thromb Vasc Biol 2002, 22:765-771.
14. Ye S: Polymorphism in matrix metalloproteinase gene promoters implication in regulation of gene expression and susceptibility of various diseases. Matrix Biol 2000, 19:623-629.
15. Corcoran ML, Stetler-Stevenson WG, DeWitt DL, Wahl LM: Effect of cholera toxin and pertussis toxin on prostaglandin H synthase-2, prostaglandin E2, and matrix metalloproteinase production by human monocytes. Arch Biochem Biophys 1994, 310:481-488.
16. Galis ZS, Muszynski M, Sukhova GK, Simon-Morrissey E, Libby P: Enhanced expression of vascular matrix metalloproteinases induced in vitro by cytokines and in regions of human atherosclerotic lesions. Ann N Y Acad Sci 1995, 748:501-507.
17. Siwik DA, Chang DL, Colucci WS: Interleukin-1 beta and tumor necrosis factor-alpha decrease collagen synthesis and increase matrix metalloproteinase activity in cardiac fibroblasts in vitro. Circ Res 2000, 86:1259-1265.
18. Feinberg MW, Jain MK, Werner F, Sibinga NE, Wiesel P, Wang H, Topper JN, Perrella MA, Lee ME: Transforming growth factor-beta 1 inhibits cytokine-mediated induction of human metalloelastase in macrophages. J Biol Chem 2000, 275:25766-25773.
19. Uzui H, Harpf A, Liu M, Doherty TM, Shukla A, Chai NN, Tripathi PV, Jovinge S, Wilkin DJ, Asotra K, Shah PK, Rajavashisth TB: Increased expression of membrane type 3-matrix metalloproteinase in human atherosclerotic plaque: role of activated macrophages and inflammatory cytokines. Circulation 2002, 106:3024-3030.
20. Creemers EE, Cleutjens JP, Smits JF, Daemen MJ: Matrix metalloproteinase inhibition after myocardial infarction: a new approach to prevent heart failure? Circ Res 2001, 89:201-210.
21. Damas JK, Waehre T, Yndestad A, Ueland T, Muller F, Eiken HG, Holm AM, Halvorsen B, Froland SS, Gullestad L, Aukrust P: Stromal cell-derived factor-1 alpha in unstable angina: potential anti-inflammatory and matrix-stabilizing effects. Circulation 2002, 106:36-42.
22. Fabunmi RP, Sukhova GK, Sugiyama S, Libby P: Expression of tissue inhibitor of metalloproteinases-3 in human atheroma and regulation in lesion-associated cells: a potential protective mechanism in plaque stability. Circ Res 1998, 83:270-278.
23. Newman KM, Ogata Y, Malon AM, Irizarry E, Gandhi RH, Nagase H, Tilson MD: Identification of matrix metalloproteinases 3 (stromelysin-1) and 9 (gelatinase B) in abdominal aortic aneurysm. Arterioscler Thromb 1994, 14:1315-1320.
24. Thompson RW, Holmes DR, Mertens RA, Liao S, Botney MD, Mecham RP, Welgus HG, Parks WC: Production and localization of 92-kilodalton gelatinase in abdominal aortic aneurysms: an elastolytic metalloproteinase expressed by aneurysm-infiltrating macrophages. J Clin Invest 1995, 96:318-326.
25. Freestone T, Turner RJ, Coady A, Higman DJ, Greenhalgh RM, Powell JT: Inflammation and matrix metalloproteinases in the enlarging abdominal aortic aneurysm. Arterioscler Thromb Vasc Biol 1995, 15:1145-1151.
26. Tamarina NA, McMillan WD, Shively VP, Pearce WH: Expression of matrix metalloproteinases and their inhibitors in aneurysms and normal aorta. Surgery 1997, 122:264-272.
27. Curci JA, Liao S, Huffman MD, Shapiro SD, Thompson RW: Expression and localization of macrophage elastase (matrix metalloproteinase-12) in abdominal aortic aneurysms. J Clin Invest 1998, 102:1900-1910.
28. Pyo R, Lee JK, Shipley JM, Curci JA, Mao D, Ziporin SJ, Ennis TL, Shapiro SD, Senior RM, Thompson RW: Targeted gene disruption of matrix metalloproteinase-9 (gelatinase B) suppresses development of experimental abdominal aortic aneurysms. J Clin Invest 2000, 105:1641-1649.
29. Allaire E, Forough R, Clowes M, Starcher B, Clowes AW: Local overexpression of TIMP-1 prevents aortic aneurysm degeneration and rupture in a rat model. J Clin Invest 1998, 102:1413-1420.
30. Carrell TW, Burnand KG, Wells GM, Clements JM, Smith A: Stromelysin-1 (matrix metalloproteinase-3) and tissue inhibitor of metalloproteinase-3 are overexpressed in the wall of abdominal aortic aneurysms. Circulation 2002, 105:477-482.
31. Silence J, Lupu F, Collen D, Lijnen HR: Persistence of atherosclerotic plaque but reduced aneurysm formation in mice with stromelysin-1 (MMP-3) gene inactivation. Arterioscler Thromb Vasc Biol 2001, 21:1440-1445.
32. Senzaki H, Masutani S, Kobayashi J, Kobayashi T, Nakano H, Nagasaka H, Sasaki N, Asano H, Kyo S, Yokote Y: Circulating matrix metalloproteinases and their inhibitors in patients with Kawasaki disease. Circulation 2001, 104:860-863.
33. Lamblin N, Bauters C, Hermant X, Lablanche JM, Helbecque N, Amouyel P: Polymorphisms in the promoter regions of MMP-2, MMP-3, MMP-9 and MMP-12 genes as determinants of aneurysmal coronary artery disease. J Am Coll Cardiol 2002, 40:43-48.
34. Henney AM, Wakeley PR, Davies MJ, Foster K, Hembry R, Murphy G, Humphries S: Localization of stromelysin gene expression in atherosclerotic plaques by in situ hybridization. Proc Natl Acad Sci U S A 1991, 88:8154-8158.
35. Galis ZS, Sukhova GK, Lark MW, Libby P: Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J Clin Invest 1994, 94:2493-2503.
36. Galis ZS, Sukhova GK, Kranzhofer R, Clark S, Libby P: Macrophage foam cells from experimental atheroma constitutively produce matrix-degrading proteinases. Proc Natl Acad Sci U S A. 1995, 92:402-406.
37. Prescott MF, Sawyer WK, Von Linden-Reed J, Jeune M, Chou M, Caplan SL, Jeng AY: Effect of matrix metalloproteinase inhibition on progression of atherosclerosis and aneurysm in LDL receptor-deficient mice overexpressing MMP-3, MMP-12, and MMP-13 and on restenosis in rats after balloon injury. Ann N Y Acad Sci 1999, 878:179-190.
38. Hartnell GC, Parnell BM, Pridie RB: Coronary artery ectasia. Its prevalence and clinical significance in 4993 patients. Br Heart J 1985, 54:392-395.
39. Berkoff HA, Rowe GG: Atherosclerotic ulcerative disease and associated aneurysms of the coronary arteries. Am Heart J 1975, 90:153-158.
40. Schoenhagen P, Vince DG, Ziada KM, Kapadia SR, Lauer MA, Crowe TD, Nissen SE, Tuzcu EM: Relation of matrix-metalloproteinase 3 found in coronary lesion samples retrieved by directional coronary atherectomy to intravascular ultrasound observations on coronary remodeling. Am J Cardiol 2002, 89:1354-1359.
41. Kai H, Ikeda H, Yasukawa H, Kai M, Seki Y, Kuwahara F, Ueno T, Sugi K, Imaizumi T: Peripheral blood levels of matrix metalloproteinases-2 and -9 are elevated in patients with acute coronary syndromes. J Am Coll Cardiol 1998, 32:368-372.
42. Brown DL, Hibbs MS, Kearney M, Loushin C, Isner JM: Identification of 92 kD gelatinase in human coronary atherosclerotic lesions: Association of active enzyme synthesis with unstable angina. Circulation 1995, 91:2125-2131.
43. Domanovits H, Schillinger M, Mullner M, Holzenbein T, Janata K, Bayegan K, Laggner AN: Acute phase reactants in patients with abdominal aortic aneurysm. Atherosclerosis 2002, 163:297-302.
44. Luan Z, Chase AJ, Newby AC: Statins inhibit secretion of metalloproteinases-1, -2, -3, and -9 from vascular smooth muscle cells and macrophages. Arterioscler Thromb Vasc Biol 2003, 23:769-775.
45. Cipollone F, Prontera C, Pini B, Marini M, Fazia M, De Cesare D, Iezzi A, Ucchino S, Boccoli G, Saba V, Chiarelli F, Cuccurullo F, Mezzetti A: Overexpression of functionally coupled cyclooxygenase-2 and prostaglandin E synthase in symptomatic atherosclerotic plaques as a basis of prostaglandin E(2)-dependent plaque instability. Circulation 2001, 104:921-927.
46. Cheng L, Mantile G, Pauly R, Nater C, Felici A, Monticone R, Bilato C, Gluzband YA, Crow MT, Stetler-Stevenson W, Capogrossi MC: Adenovirus-mediated gene transfer of the human tissue inhibitor of metalloproteinase-2 blocks vascular smooth muscle cell invasiveness in vitro and modulates neointimal development in vivo. Circulation 1998, 98:2195-2201.